American Herbal Products Association (AHPA) > News > AHPA in the News

AHPA in the News

Dietary supplement, other herbal product, and cannabis operations identified as “essential businesses” and “critical infrastructure”

Designation implied by numerous regulatory agencies; explicit in California

FDA to limit domestic inspections to “mission critical” cases; pre-announce the majority of such inspections; waive certain FSMA onsite audit requirements

Much of the teleconference was focused on the Agency’s online resources, such as its FAQ page, which was recently updated

The U.S. Food and Drug Administration (FDA) convened a teleconference meeting on March 18 (FDA Briefing for Foods Stakeholders on Coronavirus Disease 2019 (COVID-19)), which was attended by AHPA president Michael McGuffin and by representatives of AHPA’s general counsel, Kleinfeld, Kaplan & Becker, LLP.

AHPA Hemp-CBD Supplement Congress

AHPA Hemp-CBD Supplement Congress

RESCHEDULED -- Aug. 26-27

Due to overwhelming demand, AHPA is presenting a second, expanded Hemp-CBD Supplement Congress in Portland, OR to provide companies with an understanding of federal and state legal and regulatory obligations and current issues and opportunities in the hemp-CBD market.

AHPA COVID-19 Information & Resources Web Center

Answers to FAQs regarding COVID-19 impact on dietary supplements and food

AHPA has compiled answers to frequently asked questions and resources to help prepare for and respond to COVID-19. This page will be revised and updated regularly as new information about the novel coronavirus (SARS-CoV-2) and possible impacts on the herbal products industry and the people who work in this trade becomes available.

AHPA Cannabis Committee Celebrates a Decade of Industry Leadership

AHPA Cannabis Committee Celebrates a Decade of Industry Leadership

For 10 years AHPA’s Cannabis Committee has been actively involved in the regulatory, legislative, and technical aspects of moving cannabis (including hemp-CBD) into the legal marketplace

Silver Spring, MD – The American Herbal Products Association (AHPA), the voice of the herbal products industry, celebrates the 10-year anniversary of its Cannabis Committee today. The Committee was established on March 10, 2010 to address issues related to the safe use and responsible commerce of legally-marketed products derived from Cannabis species, including hemp and hemp-derived cannabidiol (CBD).
Adverse Event Reporting Tells the Story of Dietary Supplement Safety

Adverse Event Reporting Tells the Story of Dietary Supplement Safety

FDA AER data often lacks fields that may prevent misinterpretation, including FDA’s assessment of causation

Washington, D.C. — At the initial Congressional Dietary Supplement Caucus briefing of 2020, held last week, Dr. Richard Kingston, president, regulatory and scientific affairs and co-founder of SafetyCall International, educated congressional staffers on the types of evidence used to monitor dietary supplement safety, including adverse event reports, emergency room visits and poison control center data. Dr. Kingston is an expert on clinical toxicology and pharmacology, poison control, product post-market surveillance, and drug and dietary supplement safety.

February 2020 AHPA in the News


Industry Coalition Reminds Consumers, Retailers that Dietary Supplements May Not Claim to Cure, Prevent Coronavirus

Some marketers of dietary supplements or other products may be promoting them with claims of prevention or treatment of Coronavirus

The U.S. dietary supplement industry is aware of the growing concern regarding the Novel Coronavirus (2019-nCoV) and of the public’s desire to protect itself against the virus. The four leading trade associations representing the dietary supplement industry support the responsible sale and use of vitamins, minerals, herbs and other dietary supplements that provide many positive benefits promoting better health and wellness. However, we are concerned that some marketers of dietary supplements or other products may be promoting them with claims of prevention or treatment of Coronavirus.

January 2020 AHPA in the News


AHPA submits comments to USDA on domestic hemp production program

Significant room for improvement in the hemp production Interim Final Rule and the subsequent Final Rule

In comments submitted to U.S. Department of Agriculture (USDA), Agricultural Marketing Service (AMS), AHPA requested numerous, significant revisions to the Interim Final Rule (IFR) that establishes a domestic hemp production program before a Final Rule is promulgated in 2021.
RSS
12345678

2020 Annual Fund Sponsors

   

AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.